A new screening strategy and whole‐exome sequencing for the early diagnosis of maturity‐onset diabetes of the young
Authors:
- 4 July 2020
- journal article
- research article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 37 (5) , e3381
Abstract
Aims: This study aimed to establish a systematic screening strategy to select candidates for genetic testing among patients with maturity‐onset diabetes of the young (MODY) and to accomplish early diagnosis of MODY.Materials and methods: We enrolled 1478 sporadic patients from the outpatient department of endocrinology. Out of the1478 patients, 1279 participants were successfully screened according to the “AACM” strategy, which includes the age of onset, autoantibody to islet antigen, C‐peptide and metabolic syndrome. Another six probands and their families who fulfilled the common clinical criteria for MODY were also examined for causative gene mutations. Whole‐exome sequencing (WES) was performed to examine the mutations.Results: A total of 24 out of 1279 sporadic patients with newly diagnosed diabetes were eligible for genetic testing. Mutations were found in 4/24 participants in the cohort, as well as in 2/6 pedigrees. A likely pathogenic alteration, a likely benign alteration and three alterations with uncertain significance were identified with WES. Most of the mutant genes recognised in our trial were not the most common causative genes of MODY, and all of the mutations were specifically reported in Asian patients only, suggesting a unique genetic background of MODY in different ethnicities.Conclusions: In this systematic study of MODY in a new‐onset diabetes cohort, MODY cases were incorrectly diagnosed as type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM), suggesting that an observant clinician is necessary for early and correct MODY diagnosis. This systematic approach to screening is practical and specific enough to identify patients who are most appropriate for genetic testing.Keywords
Funding Information
- National Natural Science Foundation of China (81873634 81400783)
This publication has 43 references indexed in Scilit:
- A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metforminDiabetologia, 2018
- Use of oral antidiabetic drugs in the treatment of maturity‐onset diabetes of the young: A mini reviewDiabetes/Metabolism Research and Reviews, 2017
- Monogenic diabetes: Implementation of translational genomic research towards precision medicineJournal of Diabetes, 2016
- Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic DiabetesDiabetes Care, 2016
- Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase MutationDiabetes Care, 2015
- Prevalence, Characteristics and Clinical Diagnosis of Maturity Onset Diabetes of the Young Due to Mutations in HNF1A, HNF4A, and Glucokinase: Results From the SEARCH for Diabetes in YouthThe Journal of Clinical Endocrinology & Metabolism, 2013
- Prevalence of monogenic diabetes in the population-based Norwegian Childhood Diabetes RegistryDiabetologia, 2013
- Prevalence of monogenic diabetes amongst Polish children after a nationwide genetic screening campaignDiabetologia, 2012
- Diagnosis and management of maturity onset diabetes of the young (MODY)BMJ, 2011
- Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the youngDiabetologia, 2008